Page URL:

Gene therapy hope for Alzheimer's

29 April 2004
By BioNews
Appeared in BioNews 256

Injecting genetically modified (GM) skin cells into the brain appears to slow the effects of Alzheimer's disease, and could lead to a new treatment for this disorder, US researchers say. Scientists at the University of California, San Diego (UCSD) presented the results of a small, preliminary study at the American Academy of Neurology meeting, held in San Francisco last week. The results of the trial, initially designed to test the safety of the new gene therapy technique, suggest that it could halve the rate of mental decline in Alzheimer's disease patients.

Alzheimer's disease is caused by the gradual death of certain brain cells, especially in the areas involved in memory. Current drug treatments can help slow the progression of the disease, but only by around five per cent at best, says the UCSD team leader Mark Tuszynski. To test their new gene therapy treatment, he and his colleagues removed samples of skin from eight people in the early stages of Alzheimer's disease. They grew the skin cells in the laboratory, and genetically altered them so that they produced a protein called nerve growth factor (NGF), which prevents cell death in the brain. The team then injected millions of these 'GM' skin cells into ten different sites in the brain areas affected by the disease.

In two of the volunteers, the surgery was unsuccessful, but the other six participants showed a 50 per cent drop in the expected rate of mental decline. And one method of measuring mental ability showed a 65 per cent reduction in the rate of decline, in participants followed for more than 18 months after the operation. Tuszynski calls the results 'intriguing', adding that 'if these effects are borne out in larger, controlled trials, this could be a significant advance over existing therapies for Alzheimer's disease'.

The team plan to carry out a larger trial later this year - but this time, they will inject a modified virus directly into the brain to trigger NGF production, rather than using skin cells. The second trial will include 30-40 patients, and will have a control group who only receive surgery, and not the gene therapy. The results should be available in about a year and a half, says Tuszynski, and if everything goes well, the new treatment could be available in four years.

Gene therapy appears to slow Alzheimer's, research finds
Los Angeles Times |  28 April 2004
Gene therapy surgery helps Alzheimer's - study
Reuters |  27 April 2004
GM skin cells help treat Alzheimers
Nature News |  28 April 2004
New gene therapy to tackle dementia
The Daily Telegraph |  28 April 2004
23 February 2009 - by Alison Cranage 
A study shows that people who have a parent with Alzheimer's disease or dementia may be more likely to have poor memory in middle age, if they also carry a gene called ApoEe4. The findings were presented at the American Academy of Neurology's 61st Annual Meeting in...
31 March 2008 - by Dr Karen Devine 
The journal Stem Cells and Development has announced the results of an exciting new research project being carried out by a collaboration of researchers from the University of Florida, Yale University, New Haven, Cedars Sinai Medical Centre, Los Angeles, Saneron CCEL Therapeutics, Incorporated and The Saintama Medical...
22 January 2007 - by Dr Laura Bell 
By Dr Laura Bell: New research published early online in the journal Nature Genetics has linked mutations in the SORL1 gene with an increased risk of developing Alzheimer's disease. Alzheimer's disease is a progressive, degenerative and irreversible brain disorder that causes intellectual impairment, disorientation and eventually death. It is estimated...
25 August 2005 - by BioNews 
A fault in a gene that plays a major role in the growth of the body's vascular system may be involved in Alzheimer's disease. This error causes cells to be unable to form a blood supply system and die, supporting a belief that Alzheimer's is a neurovascular disease. Researchers at...
25 April 2005 - by BioNews 
Six patients taking part in a gene therapy trial for Alzheimer's disease are showing an improvement in their condition, a US team reports. Scientists at the University of California, San Diego (UCSD) have shown that injecting genetically modified skin cells into the brain appears to slow the effects of the...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.